Answers are grounded in this paper and cite their sources.
Total synthesis demonstrates effective construction of Koshidacin A in peptides, implying potential for new drug design.
Koshidacin A is a cyclic tetrapeptide isolated from the Okinawan fungus, Pochonia boninensis FKR‐0564, along with its oxidized form, Koshidacin B. These peptides fall into a series of cyclic tetrapeptides made of three hydrophobic amino acids and a fourth amino acid with a hydrophilic side chain. We report a total synthesis of Koshidacin A, which relies on the asymmetric synthesis of the hydrophilic amino acid from ( S )‐homo‐Garner aldehyde and using a combination of Sharpless asymmetric epoxidation and Payne rearrangement as the key steps.
No takes yet. Share an insight, caveat, or question.
Kapri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: